Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
30 results loaded, newest first. End of these results.
Golub Capital BDC (NASDAQ: GBDC ) released third-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Golub Capital BDC reported improved f
The company reported results for the period ended 31 May 2026 and said CEO Jerry Randall intends to retire from the role. It also highlighted revenue growth, a share buyback programme and recent disposals and acquisitions.
Henry Schein (NASDAQ: HSIC ) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Henry Schein Inc reported strong financial performance in the se
Worksport (NASDAQ: WKSP ) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available
B2Gold (TSX: BTO ) held its second-quarter earnings conference call on Friday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary B2Gold Corporation reported consolidated gold production of appro
B2Gold (AMEX: BTG ) reported second-quarter financial results on Friday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. The full earnings call is available at Summary B2Gold Corpo
Icecure Medical (NASDAQ: ICCM ) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Icecure Medical reported a 45% year-over-year reve
On Thursday, Kolibri Global Energy (NASDAQ: KGEI ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summa
On Thursday, Kolibri Global Energy (TSX: KEI ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Kolibri Global Energy Inc. reported its highest
HUTCHMED (China) (NASDAQ: HCM ) released quarterly financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary HUTCHMED (
Oracle reported record first-quarter revenue of $19.3 billion, up 30% year over year, with cloud infrastructure revenue up 121% to $7.4 billion. The company also completed a $20 billion equity issuance and guided Q2 revenue growth of 30% to 34%.
Currency Exchange Intl said Q3 2026 total revenue rose 5% to $22.4 million, led by a 54% increase in payments revenue that offset a 4% drop in banknotes revenue. Adjusted EBITDA increased 3% to $8.5 million and adjusted net income rose 31% to $5.6 million.
Macy's said second-quarter net sales, comparable sales, adjusted EBITDA and adjusted diluted EPS all exceeded guidance. The company reported 2.7% comparable sales growth and said adjusted EPS was 63 cents, helped by tariff refunds.
Signet Jewelers said second-quarter comps rose over 2% and adjusted EPS grew more than 35%, while management raised full-year guidance and highlighted brand and website upgrades.
Core & Main reported second-quarter fiscal 2026 net sales up 2.5% to about $2.1 billion and adjusted EBITDA up 3% to $274 million, while reaffirming full-year guidance for sales and adjusted EBITDA.
U.S. stocks ended the week mixed after August jobs data beat expectations, with employers adding 162,000 positions and unemployment holding at 4.1%, boosting bets the Federal Reserve could raise rates in September.
Palantir Technologies Inc. (NYSE: PLTR ) stock dropped on Tuesday, primarily driven by profit-taking following a 7% surge during Monday’s trading session. On Tuesday, Nasdaq futures are down 0.74% while S&P 500 futures have gained 0.34%. Read Also: Stock Market Today: Dow Jones Futures Gain as Coca-Cola Jumps After Q2
PACCAR (NASDAQ: PCAR ) reported its second-quarter financial results on Tuesday, posting quarterly earnings of $1.43 per share. The result beat the analyst consensus estimate of $1.35 per share and represented an increase from earnings of $1.37 per share recorded in the same period last year. Quarterly Revenue And Cash
Community Health Sys (NYSE: CYH ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Community Health Sys reported a 9.8
Honeywell Intl (NASDAQ: HON ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Honeywell Intl reported a strong second quarter with 4% o
Johnson & Johnson (NYSE: JNJ ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call at Summary Johnson & Johnson reported st
() -- Healthcare stocks were declining premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.6% and the iShares Biotechnology ETF (IBB) 0.1% lower. Elevance Health (ELV) shares were down more than 8% after the company reported lower Q2 adjusted earnings. Johnson & Johnson (JNJ) stoc
() -- Johnson & Johnson (JNJ) reported fiscal Q2 adjusted earnings Wednesday of $2.90 per diluted share, up from $2.77 a year earlier. Analysts polled by FactSet expected $2.85. Reported sales for the fiscal quarter ended June 28 were $25.31 billion, up from $23.74 billion a year earlier. Analysts surveyed by FactSet e
$JNJ Johnson & Johnson Q2 Earnings
Adj EPS $2.90 (est $2.85) -Sales $25.31B (est 25.04B) -Medtech Sales $8.93b (est $8.99b) -Medicine Revenue $16.38b (est $16.12b) -Sees FY Sales $100.88 To $101.48, Saw $100.3b To $101.3b -Sees FY Adj EPS $11.60 To $11.75, Saw $11.45 To $11.65 Sees FY Sales $100.8b To $101.4b, Saw $100.3b To $101.3b
() -- Copyright © 2026. All rights reserved. does not provide investment advice. Unauthorized reproduction is strictly prohibited.
Health care giant Johnson & Johnson (NYSE: JNJ ) reports second-quarter financial results on Wednesday before the market opens. Here are the earnings estimates, what experts are saying and key items to watch. Johnson & Johnson Q2 Earnings Estimates Analysts expect Johnson & Johnson to report second-quarter revenue of $
() -- Biopharma pricing power will be the key swing factor for Q2 earnings as companies with cleaner growth outlooks continue to outperform peers facing loss-of-exclusivity headwinds, Bank of America said in a note Friday. Merck & Co (MRK), AbbVie (ABBV), Jazz Pharmaceuticals (JAZZ) and Ionis Pharmaceuticals (IONS) rem
Johnson & Johnson Q2 2026 Earnings
Johnson & Johnson (NYSE: JNJ ) will release its second quarter earnings report before the opening bell on Wednesday, July 15. Analysts expect the New Brunswick, New Jersey-based company to report quarterly earnings of $2.85 per share, up from $2.77 per share in the year-ago period. The consensus estimate for Johnson &